Michael Bruckman
@mikebruckman
CEO for Haima therapeutics
ID: 396907693
http://www.haimatherapeutics.com 23-10-2011 23:20:13
547 Tweet
195 Followers
266 Following
Heading to #Boston for Biotechnology Innovation Organization #BIO2023 - looking forward to connecting with #entrepreneurs, #biotech businesses, and #investors in #biotech
Day 1 of Biotechnology Innovation Organization #BIO2023 off to a great start. 10 more meetings and 3 receptions to go! #fundraising #Partnering
Our 121st is with Michael Bruckman — CEO Haima Therapeutics (>$13 million in government funding) — on the vast implications that Haima’s synthetic platelet technology can have on bleeding and the field of blood-related diseases at large ! (Full episode in thread)
Thrilled to share final version of our collaborative studies with @cecile_denis Peter Lenting Julie Rayes Haima Therapeutics labs on evaluating #SynthoPlate in von Willebrand disease murine models published in @BloodJournal sciencedirect.com/science/articl…
Thrilled to be part of four exciting projects to be presented at upcoming ISTH #ISTH2023 in Montreal! Collaborations w Evi Stavrou Jordan Shavit Matthew D. Neal, MD Haima Therapeutics #PedramMohseni labs. Research supported by @nih_nhlbi CDMRP CWRU Biomedical Engineering CWRU Engineering CWRU School of Medicine See my #ClotFamily soon!
Excited to see this talk by Dante Disharoon out of the Anirban Sen Gupta lab at #ISTH2023! The current state of #pointofcare hemostatic monitoring is blunt at best and limits both study and treatment of #TIC - great to have forward movement in this space.
Haima is looking for a motivated young scientist to join our team as an industry postdoc with potential to transition to a full time role with the company. Message me directly at [email protected] or through Linkedin linkedin.com/jobs/view/3682…
Come join our team at Haima Therapeutics to advance platelet-inspired therapeutic technologies for treating a variety of pathologies in hemostasis, thrombosis and thromboinflammation areas! haimatherapeutics.com Please RT! 🙏🏽
2020 Sen Gupta Lab PhD graduate Ujjal Didar Singh Sekhon participated with Case Western Reserve postdoctoral fellow Dante Disharoon in the #DARPA Forward symposium at Ohio State in 2022. To read what Sekhon has done since graduating, click the link and scroll to page 20! case.edu/bme/sites/case…
Haima is seeking a postdoc to support our CMC activities. Please see the job description and contact us ASAP. haimatherapeutics.com/2023postdoc Anirban Sen Gupta Matthew D. Neal, MD Tim Pelura Philip Spinella, MD Jerrold Levy, MD
The Sen Gupta Lab is recruiting a post-doc researcher in hemostasis/wound healing areas. Experience in one or more is preferred: 1. Supramolecular biomaterials assemblies, hydrogels 2. Hematology, Immunology 3. Microfluidics, Tissue Chips 4. In vivo wound models Please RT🙏🏽🙏🏽
First demonstration of #SynthoPlate hemostatic efficacy in rabbit polytrauma model. Collaboration between Sen Gupta Lab CWRU Biomedical Engineering CWRU Engineering The Neal Lab Matthew D. Neal, MD Pitt Trauma & Transfusion Medicine Research Center Haima Therapeutics Michael Bruckman supported by CDMRP grant. journals.lww.com/jtrauma/fullte…
End of the semester gathering for Sen Gupta Lab …..looking forward to wrapping up another successful year of research adventures, and continuing the journey in 2024! #ProudPI #TeamSport
CMO <-> CTO Haima Therapeutics showdown at #SynthoPlate #RabbitModel poster ISTH #ISTH2024 Matthew D. Neal, MD Michael Bruckman Ujjal Didar Singh Sekhon CWRU Biomedical Engineering CWRU Engineering Pitt Trauma & Transfusion Medicine Research Center
